
Patient Square Capital: A healthcare investment firm fostering growth in health-focused organizations.
patientsquarecapital.comCrawled Oct 15, 2026
Patient Square Capital is a dedicated health care investment firm.
Patient Square Capital announced that Adam Fliss joined the firm as a founding partner and general counsel on January 5, 2021.
On February 1, 2021, Patient Square Capital announced that Alex Albert and Neel Varshney, M.D., had joined the firm as Founding Partners. Patient Square Capital is a dedicated health care investment firm.
Patient Square Capital announced that Karr Narula joined the firm as a founding partner on March 23, 2021. He previously spent 13 years at KKR.
Adam Fliss has over 19 years of experience in alternative investments, law and government affairs. Before Patient Square, Adam Fliss was General Counsel of TPG Capital and an Associate in the private equity group at Ropes & Gray.
Colin Shannon is a senior advisor to Patient Square Capital and former chairman and chief executive officer of PRA Health Sciences. He also held executive roles at Pharmaceutical Product Development Inc. (PPD), including executive vice president of global clinical operations.
James Boylan is a senior advisor to Patient Square Capital and chief executive officer of Enavate Sciences. He previously served as president and head of investment banking at SVB Leerink.
Stuart Kurlander is a senior advisor to Patient Square Capital and former global co-chair of the Healthcare & Life Sciences Practice and the Israel Practice at Latham & Watkins. He founded Latham & Watkins’ Healthcare & Life Sciences Practice in Washington, DC.
Andrew Li is an Associate Director in Transformation and Growth at Patient Square Capital. Before joining Patient Square, Andrew Li worked at The Global Fund, helping implement investments in COVID-19 mitigation and pandemic preparedness.
Patient Square Capital established Patient Square Insights (PSI), a research and due diligence center.